NAGE ChromaDex: Nilai perusahaan marang pendapatan

Simbol resmi perusahaan ChromaDex (NAGE)

The EV/Sales chart illustrates the business value-to-revenue dynamics, where the 659.66 mark indicates the current state. Growth in Niagen sales and the expansion of partnerships within the dietary supplement sector are driving the current momentum for Chromadex Corp (NAGE). Simultaneously, the company is implementing ESG standards by minimizing plastic use and conserving resources. Supply chain stability is ensured through in-house laboratories and rigorous quality control of precision components.

niagenbioscience.com (NAGE): Rasio nilai perusahaan marang pendapatan saka 23.11.2025 nganti 20.11.2026

NAGE (ChromaDex Corp): rincian analitis lan laporan miturut indikator

- kuotasi saiki lan rata-rata prakiraan nilai:
- data kapitalisasi saham perusahaan:
Pambiji fundamental perusahaan:Chromadex Corp
Produk sing diprodhuksi ChromaDex Corp.

This ratio determines the market value of the business relative to sales volume, excluding the impact of debt load. The calculation combines market capitalization and net debt, allowing for an assessment of the real price per unit of revenue. By analyzing the EV/Sales history, an investor identifies whether an asset is overvalued or possesses growth potential. For Chromadex Corp (NAGE), this is critical when scaling Niagen sales through global partners. The metric demonstrates how much the market is willing to pay for the company's leadership in the NAD+ booster segment.

Analisis pesaing Chromadex Corp

ISRG - Multiplikator EV/Sales|DHR: Multiplikator EV/Sales|Multiplikator nilai perusahaan marang pendapatan BD (BDX)|Rasio nilai perusahaan marang pendapatan STERIS plc|Rasio nilai perusahaan marang pendapatan WST (West Pharmaceutical Services)|Nilai perusahaan marang pendapatan BAX (Baxter Corp)|Masimo - Rasio nilai perusahaan marang pendapatan|Stevanato Group S.p.A. - Nilai perusahaan marang pendapatan|Rasio total nilai perusahaan marang pendapatan Teleflex Inc (TFX)|MMSI - Rasio nilai perusahaan marang pendapatan|Rasio total nilai perusahaan marang pendapatan Envista Holdings Corp NVST|ICUI: Multiplikator EV/Sales|Rasio nilai perusahaan marang pendapatan XRAY|LMAT (LeMaitre Corp) - Multiplikator EV/Sales|ATRC (AtriCure Inc) - Koefisien nilai perusahaan marang pendapatan|Multiplikator EV/Sales STAA|Nilai perusahaan marang pendapatan ZimVie Inc. ZIMV|Multiplikator EV/Sales ANGO (angiodynamics.com)|Multiplikator EV/Sales cerus.com CERS|teknova.com - Multiplikator EV/Sales|Rasio nilai perusahaan marang dodolan Monogram Technologies Inc. (MGRM)|Sharps Technology, Inc. (STSS) - Rasio nilai perusahaan marang pendapatan|Multiplikator nilai perusahaan marang pendapatan InfuSystem Inc (INFU)|UTMD (Utah Medical Products Inc.) - Multiplikator EV/Sales|Multiplikator nilai perusahaan marang pendapatan KORU Medical Systems KRMD|Rasio nilai perusahaan marang pendapatan Nyxoah SA (NYXH)|Koefisien nilai perusahaan marang pendapatan MBOT|Multiplikator EV/Sales PDEX (Pro-Dex Inc.)|Koefisien nilai perusahaan marang pendapatan ZTEK (Zentek Limited)|elutia.com - Multiplikator EV/Sales|Nilai bisnis marang pendapatan MLSS (milestonescientific.com)|NXGL (NEXGEL Inc.) - Nilai perusahaan marang pendapatan|Retractable Technologies - Nilai bisnis marang pendapatan|Rasio nilai perusahaan marang pendapatan harvardbioscience.com|Femasys Corp (FEMY) - Rasio total nilai perusahaan marang pendapatan|Multiplikator EV/Sales MHUA|Predictive Oncology Inc. - Rasio nilai perusahaan marang pendapatan|Multiplikator EV/Sales CJMB (Callan JMB Inc)|Multiplikator EV/Sales Atrion Corp ATRI|NeuroMetrix Corporation - Multiplikator EV/Sales